Menu
Recruiting NCT07032818

Adapted Hospital Discharge Intervention: the CONNECT Pilot

No phase Interventional Communication Research

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Additional post discharge phone call.
Who it may be relevant to
Registry conditions: Communication Research. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Communication Outreach for Navigation and Needs-based Care Transitions (CONNECT): A Pilot Randomized Controlled Trial

Overview

Hospital discharge is a dangerous time for patients: one in five will suffer an adverse event, such as a medication error, and nearly 25% will be readmitted within 30 days. This time is even more dangerous for patients with who face communication barriers, including those with non-English language preference (NELP), low health literacy, and the elderly. The investigators will pilot a post-discharge educational intervention to reinforce written discharge instructions (known as the After Visit Summary or AVS) using a randomized controlled trial design (2:1 intervention: control). The control group will receive current standard of care discharge education which includes a nurse reviewing their AVS and an automated call in English that allows patients to numerically select types of problems/questions that are then escalated to a nurse who should return their call within a few days. The intervention group will receive the standard of care discharge education with the AVS and an additional post-discharge educational call delivered by a registered nurse or other qualified health professional with the option to have written instructions professionally translated and sent via MyChart message--if available in their preferred language.

Interventions

  • Other Additional post discharge phone call
    24-72 hours after hospital discharge, a nurse will call participants to review the written After Visit Summary (AVS) given at discharge, including primary diagnosis, self-care instructions, emergency plan, medication changes, how and why to take medication, and scheduled follow up. These phone calls will take on average 10-15 minutes.

Primary outcome measures

  • Retention success by linguistic group [Time frame: 12 months]
  • Fidelity to the intervention [Time frame: 12 months]
Secondary outcome measures (3)
  • Acceptability of the intervention [Time frame: 12 months]
  • Feasibility of the intervention [Time frame: 12 months]
  • Patient Understanding of Discharge Instruction (UDI) Scale [Time frame: 12 months]

Eligibility criteria

Inclusion criteria

  • Registered language in Epic (written or spoken) is Spanish, Haitian Creole, Portuguese, Cape Verdean, or Vietnamese
  • Admitted to medicine team at Boston Medical Center (BMC)
  • Being discharged home (to the community)

Exclusion criteria

  • On airborne infections precautions at time of recruitment
  • On C diff precautions at time of recruitment
  • On suicide precautions at time of recruitment
  • Nurse report of participant displaying cognitive impairment, ongoing delirium, or aggression
  • Discharge observed during a prior admission

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Health services research

Study locations

United States · 1 center
  • Boston Medical Center — Boston

Identifiers

NCT: NCT07032818 · H-45822 · K23MD019068-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗